{"id":26257,"date":"2014-09-18T19:46:56","date_gmt":"2014-09-18T11:46:56","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=26257"},"modified":"2014-09-18T19:21:43","modified_gmt":"2014-09-18T11:21:43","slug":"health-canada-wants-indian-drug-companys-shipments-halted-products-quarantined","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2014\/09\/18\/health-canada-wants-indian-drug-companys-shipments-halted-products-quarantined\/","title":{"rendered":"Health Canada wants Indian drug company\u2019s shipments halted, products quarantined"},"content":{"rendered":"<figure id=\"attachment_26258\" aria-describedby=\"caption-attachment-26258\" style=\"width: 500px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/09\/5268704320_73a84785b8_o.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-26258\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/09\/5268704320_73a84785b8_o.jpg\" alt=\"Photo by Bill Lyons \/ Flickr\" width=\"500\" height=\"332\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/09\/5268704320_73a84785b8_o.jpg 500w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/09\/5268704320_73a84785b8_o-300x199.jpg 300w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/a><figcaption id=\"caption-attachment-26258\" class=\"wp-caption-text\">Photo by <a href=\"https:\/\/flic.kr\/p\/92zueE\" target=\"_blank\">Bill Lyons<\/a> \/ Flickr<\/figcaption><\/figure>\n<p>OTTAWA\u2014Health Canada has asked an Indian company to voluntarily stop shipment of products to Canada, based on a review of recent manufacturing practices by the U.S. Food and Drug Administration.<\/p>\n<p>The FDA found falsification and manipulation of data issues at pharmaceutical company IPCA Laboratories, which manufactures more than 350 drug formulations.<\/p>\n<p>IPCA has not disputed the FDA findings with Health Canada, which estimates that about 21 active pharmaceutical ingredients are involved.<\/p>\n<p>The federal department has also asked Canadian companies that import products containing the active ingredients from IPCA facilities to temporarily quarantine the products.<\/p>\n<p>To date, there has been no indication that the issues identified by the FDA inspection pose a risk to health, so neither Health Canada nor the FDA has requested a recall of products already on the market.<\/p>\n<p>Health Canada says it is working with other international regulatory partners, Canadian importers and IPCA to gather more information about affected products.<\/p>\n<p>This information includes any additional testing being done, the medical necessity of the products involved, their market share and risk assessments\u2014a process that will likely take a few weeks to complete.<\/p>\n<p>\u201cAt this time, we do not expect that there will be an immediate impact on the availability of these products,\u201d a Health Canada advisory said Wednesday. \u201cThe department will work with the provinces and territories to monitor the supply situation and, if necessary, develop mitigation strategies.\u201d<\/p>\n<p>Health Canada has requested that the voluntary quarantine continue until it is satisfied that adequate measures are in place to confirm the quality of the products from IPCA facilities.<\/p>\n<p>The 60-year-old company\u2019s website says its clients include such global pharmaceutical giants as AstraZeneca, GSK, Merck, Roche and Sanofi Aventis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>OTTAWA\u2014Health Canada has asked an Indian company to voluntarily stop shipment of products to Canada, based on a review of &hellip;<\/p>\n","protected":false},"author":44,"featured_media":26258,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1482,18],"tags":[],"class_list":["post-26257","post","type-post","status-publish","format-standard","has-post-thumbnail","category-breaking","category-news-ca","mauthors-the-canadian-press"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/26257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=26257"}],"version-history":[{"count":0,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/26257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/26258"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=26257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=26257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=26257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}